Phase I Study of CCI-779 (NSC 683864, IND 61010) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumours

Trial Profile

Phase I Study of CCI-779 (NSC 683864, IND 61010) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumours

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Mar 2016

At a glance

  • Drugs Temsirolimus (Primary) ; Carboplatin; Paclitaxel
  • Indications Endometrial cancer; Ovarian cancer; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Aug 2011 Planned end date changed from 1 Apr 2009 to 1 Nov 2011 as reported by ClinicalTrials.gov.
    • 08 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 21 Jan 2009 Status changed from suspended to recruiting according to both the ClinicalTrials.gov record and the National Cancer Institute of Canada record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top